Monday, 26 November 2018

New device could monitor anticoagulant treatments to deliver personalised therapies

Researchers from CSIC, ICN2 and CIBER-BBN have designed a biosensor device based on gold nanostructures that precisely detects the presence of anticoagulant drug from a small blood sample. Treatments with anticoagulants such as Sintrom® (acenocoumarol) face the difficulty of adjusting the drug doses. This device will allow patients to self-regulate the dose.

Wednesday, 07 November 2018

Micropumps as a platform for understanding chemically propelled micromotors

ICN2 researchers investigate micropumps as a window into self-propelled micromotors and beyond. In the paper published this September in Accounts of Chemical Research, lead author Dr María José Esplandiu explains how their findings are important not only to harnessing the full potential of micro- and nanomotor technologies, but also to understanding active matter systems in nature.